Metabolon Partnership with University of Maryland School of Medicine Amish Research Program Leverages Metabolomics to Identify Novel Biomarkers read more
Metabolon, Inc. Announces $72 Million in Debt and Equity Financing to Accelerate Advancements in Precision Medicine and Innovative Drug Development Technologies read more
Metabolon Wins Five Year Contract with U.S. Army Research Institute of Environmental Medicine read more
BioTechniques: Talking Techniues | Greg Michelotti on metabolomics, precision medicine and frailty biomarkers read more
Metabolon’s Metabolomic Platform and Services Cited in More Than 3,000 Peer-Reviewed Articles across Life Sciences, Pharmaceutical/Biotech, and Applied Sciences read more
Metabolon to Offer Targeted Panels and Assays to Aid in Dysregulated Glucose Status and Related Research read more
Case Study: Circulating Lipids as Biomarkers of Host Inflammatory Responses to Acute Critical Illness read more